CO5261581A1 - Metodo para reducir o eliminar el tabaquismo - Google Patents
Metodo para reducir o eliminar el tabaquismoInfo
- Publication number
- CO5261581A1 CO5261581A1 CO01011530A CO01011530A CO5261581A1 CO 5261581 A1 CO5261581 A1 CO 5261581A1 CO 01011530 A CO01011530 A CO 01011530A CO 01011530 A CO01011530 A CO 01011530A CO 5261581 A1 CO5261581 A1 CO 5261581A1
- Authority
- CO
- Colombia
- Prior art keywords
- nicotine
- time
- tobacco
- alternative source
- unit
- Prior art date
Links
- 241000208125 Nicotiana Species 0.000 title abstract 13
- 235000002637 Nicotiana tabacum Nutrition 0.000 title abstract 13
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 abstract 12
- 229960002715 nicotine Drugs 0.000 abstract 12
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 abstract 12
- 230000003247 decreasing effect Effects 0.000 abstract 2
- 206010057852 Nicotine dependence Diseases 0.000 abstract 1
- 208000025569 Tobacco Use disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/504,560 US6660754B1 (en) | 2000-02-15 | 2000-02-15 | Method for reducing or eliminating smoking |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5261581A1 true CO5261581A1 (es) | 2003-03-31 |
Family
ID=24006789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO01011530A CO5261581A1 (es) | 2000-02-15 | 2001-02-14 | Metodo para reducir o eliminar el tabaquismo |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6660754B1 (https=) |
| EP (1) | EP1265610A4 (https=) |
| JP (1) | JP2003522789A (https=) |
| KR (1) | KR20020075795A (https=) |
| CN (1) | CN1400901A (https=) |
| AR (1) | AR032440A1 (https=) |
| AU (1) | AU782403B2 (https=) |
| BR (1) | BR0108318A (https=) |
| CA (1) | CA2400353A1 (https=) |
| CO (1) | CO5261581A1 (https=) |
| CZ (1) | CZ20022766A3 (https=) |
| EA (1) | EA004184B1 (https=) |
| EG (1) | EG22199A (https=) |
| HU (1) | HUP0301131A3 (https=) |
| MY (1) | MY127259A (https=) |
| NZ (1) | NZ520586A (https=) |
| PE (1) | PE20011221A1 (https=) |
| PL (1) | PL357013A1 (https=) |
| WO (1) | WO2001060364A1 (https=) |
| ZA (1) | ZA200207217B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050112148A1 (en) * | 2003-11-21 | 2005-05-26 | Dmitruk Victor M. | Habit based self-help method for smoking cessation |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| US20080230078A1 (en) * | 2007-03-19 | 2008-09-25 | Oby George Tolman | Method of smoking cessation |
| EP2515918B1 (en) * | 2009-12-21 | 2014-10-08 | RCP Development, Inc. | Smoking cessation lozenge containing tobacco alkaloid and silver salt |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| CN101858902B (zh) * | 2010-06-01 | 2012-12-12 | 中国科学院广州地球化学研究所 | 一种结合碳同位素比值的土壤蚀变碳酸盐的测量方法 |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| CN108685184B (zh) * | 2017-04-11 | 2020-06-16 | 常州市派腾电子技术服务有限公司 | 辅助戒烟方法及辅助戒烟装置 |
| CN107149028A (zh) * | 2017-04-17 | 2017-09-12 | 廖华勇 | 内含微量烟草气味的香口胶 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5055478A (en) | 1986-06-19 | 1991-10-08 | Cooper Thomas M | Method for stopping smoking |
| US5488962A (en) | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
| AR030092A1 (es) * | 2000-08-02 | 2003-08-13 | Smithkline Beecham Corp | Metodo para reducir o eliminar el fumar |
-
2000
- 2000-02-15 US US09/504,560 patent/US6660754B1/en not_active Expired - Lifetime
-
2001
- 2001-02-13 AR ARP010100637A patent/AR032440A1/es unknown
- 2001-02-13 MY MYPI20010641A patent/MY127259A/en unknown
- 2001-02-13 PE PE2001000154A patent/PE20011221A1/es not_active Application Discontinuation
- 2001-02-14 EG EG20010130A patent/EG22199A/xx active
- 2001-02-14 CO CO01011530A patent/CO5261581A1/es not_active Application Discontinuation
- 2001-02-15 EP EP01910708A patent/EP1265610A4/en not_active Withdrawn
- 2001-02-15 KR KR1020027010559A patent/KR20020075795A/ko not_active Withdrawn
- 2001-02-15 CA CA002400353A patent/CA2400353A1/en not_active Abandoned
- 2001-02-15 HU HU0301131A patent/HUP0301131A3/hu unknown
- 2001-02-15 BR BR0108318-0A patent/BR0108318A/pt not_active Application Discontinuation
- 2001-02-15 CN CN01804937A patent/CN1400901A/zh active Pending
- 2001-02-15 EA EA200200765A patent/EA004184B1/ru not_active IP Right Cessation
- 2001-02-15 CZ CZ20022766A patent/CZ20022766A3/cs unknown
- 2001-02-15 AU AU38289/01A patent/AU782403B2/en not_active Expired
- 2001-02-15 PL PL01357013A patent/PL357013A1/xx not_active Application Discontinuation
- 2001-02-15 WO PCT/US2001/004798 patent/WO2001060364A1/en not_active Ceased
- 2001-02-15 JP JP2001559461A patent/JP2003522789A/ja not_active Withdrawn
- 2001-02-15 NZ NZ520586A patent/NZ520586A/en not_active IP Right Cessation
-
2002
- 2002-09-09 ZA ZA200207217A patent/ZA200207217B/en unknown
-
2003
- 2003-09-24 US US10/670,922 patent/US20040058966A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA004184B1 (ru) | 2004-02-26 |
| AU3828901A (en) | 2001-08-27 |
| BR0108318A (pt) | 2003-02-18 |
| US20040058966A1 (en) | 2004-03-25 |
| MY127259A (en) | 2006-11-30 |
| KR20020075795A (ko) | 2002-10-05 |
| ZA200207217B (en) | 2003-08-04 |
| US6660754B1 (en) | 2003-12-09 |
| CA2400353A1 (en) | 2001-08-23 |
| NZ520586A (en) | 2004-11-26 |
| PL357013A1 (en) | 2004-07-12 |
| CZ20022766A3 (cs) | 2003-05-14 |
| HUP0301131A3 (en) | 2004-01-28 |
| JP2003522789A (ja) | 2003-07-29 |
| HUP0301131A2 (hu) | 2003-08-28 |
| EA200200765A1 (ru) | 2003-02-27 |
| AR032440A1 (es) | 2003-11-12 |
| CN1400901A (zh) | 2003-03-05 |
| EP1265610A1 (en) | 2002-12-18 |
| WO2001060364A1 (en) | 2001-08-23 |
| EP1265610A4 (en) | 2008-04-02 |
| AU782403B2 (en) | 2005-07-28 |
| PE20011221A1 (es) | 2002-02-07 |
| EG22199A (en) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5261581A1 (es) | Metodo para reducir o eliminar el tabaquismo | |
| ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
| NO20062181L (no) | Metode for fremstilling av aminokrotonylforbindelser | |
| AR043188A1 (es) | Metodos y composiciones para el tratamiento de enfermedades y trastornos asociados con niveles elevados de citoquinas proinflamatorias | |
| ATE401874T1 (de) | Verabreichung von capsaicinoiden | |
| PT977564E (pt) | Forscolina para promocao da massa corporal magra | |
| DK1301196T3 (da) | Stimulering af knoglevækst med peptidderivater af thrombin | |
| DK0998287T3 (da) | Anvendelse af levobupivacain | |
| IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
| DE60214527D1 (de) | Verwendung von flumazenil bei der entwicklung eines arzneimittels zur behandlung von alkoholabhängigkeit | |
| SE9603725D0 (sv) | New teatment | |
| SE0000601D0 (sv) | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet | |
| BRPI0411324A (pt) | composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes | |
| BR0211970A (pt) | Uso de bibn4096 em combinação com outras drogas antienxaqueca para o tratamento de enxaqueca | |
| SE0004710L (sv) | System och förfarande | |
| BR0313503A (pt) | Método de tratamento de sìndrome das pernas inquietas, uso do antagonista de receptor da adenoina a2a, agente terapêutico para sìndrome das pernas inquietas, e, método de tratamento da mioclonia noturna | |
| AR036591A1 (es) | Uso de la hl en hiperestimulacion ovarica controlada | |
| DK1244438T3 (da) | Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde | |
| PT1315496E (pt) | Tratamento de desordens inflamatorias | |
| ATE398134T1 (de) | Neue analoga von nitrobenzylthioinosin | |
| ITTO20020684A1 (it) | Nuovo uso dell'angelicina e di suoi analoghi strutturali. | |
| NO20054034L (no) | Fremgangsmate for behandling av hypotyroidisme. | |
| DE602004009166D1 (de) | Neue Analoga von Nitrobenzylthioinosin | |
| BR0316123A (pt) | Formulação farmacêutica aquosa, uso de uma formulação farmacêutica aquosa, e, método de tratamento de um paciente com necessidade de tratamento antitrombótico | |
| BR0211323A (pt) | Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |